Clearside Biomedical Inc buy tamam
Start price
17.06.18
/
50%
€9.63
Target price
03.06.19
€13.53
Performance (%)
-89.89%
End price
03.06.19
€0.97
Summary
This prediction ended on 03.06.19 with a price of €0.97. Massive losses of -89.89% were the result for the BUY prediction by tamam. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clearside Biomedical Inc | -0.559% | -0.559% | 3.488% | -84.549% |
| iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
| iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
| iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
| iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
Comments by tamam for this prediction
In the thread Clearside Biomedical Inc diskutieren
Clearside Biomedical: Upside Into Q4 Data And NDA Submission
Positive data in the pivotal PEACHTREE study adds an element of derisking and downside cushion.
Clinical and regulatory catalysts later this year are likely to spur a run up.
Für zukünftige Katalysatoren plant das Unternehmen die NDA für suprachoroidale CLS-TA bei Patienten mit Makulaödem im Zusammenhang mit Uveitis bei der FDA einzureichen.
The comment has been deleted